Skip to main content

Table 5 Demographic and patients’ characteristics

From: Patients' perspectives on buprenorphine subcutaneous implant: a case series

 

Patients (n = 6)

Female/Male

1/5

Age (years, mean ± SD)

48 ± 14

History of drug abuse (years, mean ± SD)

19 ± 12

Employment

truck driver (n = 1), pensioner (n = 1), shop assistant (n = 1), laborer (n = 1), clerk (n = 1), university student (n = 1)

Medical history

nil (n = 4), renal papillary adenocarcinoma (n = 1), cryoglobulinemia (n = 1), bipolar disorder (n = 1)

Main substances of abuse

IV heroin (n = 6), cocaine (n = 1), alcohol (n = 1)

Maintenance therapy dosage (mg)

2 (n = 1), 4 (n = 2), 6 (n = 1), 8 (n = 2)

Concomitant therapies

antidepressants (n = 4), anticonvulsants (n = 1), antipsychotics (n = 1)

SL bup treatment (days)

30 ≤ x ≤ 4.015

  1. SD standard deviation, SL bup sublingual buprenorphine